We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA said it won’t object to outsourcing facilities using hydroxychloroquine sulfate or chloroquine phosphate for compounding during the COVID-19 pandemic. Read More
China’s National Medical Products Administration (NMPA) has banned the importation, sale and use of Bristol-Myers Squibb’s cancer blockbuster Abraxane (nanoparticle albumin-bound paclitaxel) following an inspection in the U.S. Read More
The Canadian government has passed a law that temporarily speeds up its process for overriding drug patents, to ensure accessibility to medically necessary products during the coronavirus pandemic. Read More
In a surprise move based on public outcry, Gilead asked the FDA to rescind remdesivir’s orphan drug designation as a potential COVID-19 treatment. Read More
The FDA has said it will allow convalescent plasma to be used as an emergency treatment for patients with serious or immediately-life threatening COVID-19. Read More
India has banned almost all exports of hydroxychloroquine to protect the nation’s domestic supply of the malaria drug considered a possible treatment for COVID-19. Read More